Many women under 30 years of age do not recognize the symptoms of cervical cancer.
Researchers say a urine screening may be accurate at identifying human papillomavirus (HPV).
Cisplatin plus pemetrexed improved response rates and survival rates of patients with advanced cervical cancer.
A clinical trial is underway that may provide women with a more accurate way to detect cervical cancer.
The FDA has approved a new use against late-stage cervical cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|